Dynamic Global Events (“DGE”), a life science leader in providing B2B conferences tailored toward engaging audiences, facilitating information exchange, encouraging collaboration, and accelerating partnerships, is proud to announce its latest iteration of the Transparency and Aggregate Spend Summit on June 12-13, 2023 in Philadelphia. The event is built around providing the latest information needed to meet Open Payments, state and global transparency reporting requirements. As such, the summit promises to be an excellent opportunity for attendees to garner the knowledge and networking they need to compliantly report Health Care Provider (“HCP”) spend while building valuable transparency programs.
This year’s event will be held at The Inn at Penn in Philadelphia, Pennsylvania. It will feature leaders in transparency reporting, such as Lauren Miretsky, the Director, Global Spend Transparency at Vertex Pharmaceuticals, Eric Saharig, the Senior Associate Director, Ethics and Compliance at Boehringer Ingelheim, and Gina Dubois, the Associate Director of Compliance at Kiniksa Pharmaceuticals.
Some discussion topics will include strengthening and improving risk management of global HCP engagement and transparency compliance, explicitly examining the Italian and French Sunshine laws. It will also focus on gaining a summary of changes in Open Payments federal reporting and gauging the impact of the Department of Justice (“DOJ”) enforcement initiatives and speaker programs fraud alert on transparency reporting.
With these topics and more, the summit promises that attendees will gain strategies for managing high-risk HCP interactions, data integrity, and putting transparency data to work. They will also benefit from a live-polling benchmarking session to highlight trends and best practices while leveraging networking opportunities that guarantee peer-to-peer knowledge exchange.
The 2nd Transparency and Aggregate Spend Summit targets biopharmaceutical and medical device professionals working in various areas, transparency, aggregate spend, compliance, data analytics, monitoring and auditing, systems/IT. This event aligns with DGE’s commitment to serving the dynamic informational and networking needs of the pharmaceutical, biotechnology, medical device, healthcare, and allied industries. More importantly, it lives up to DGE’s objective of facilitating the growth of the industry and the stakeholders therein.
To learn more, please visit https://ibn.fm/FjsCe.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]